Aug 29, 2018 Cellectar Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference Learn More
Aug 20, 2018 Fractionated Dosing Improves Tolerability and Safety of Cellectar’s CLR 131 in R/R Multiple Myeloma Patients Learn More
Aug 13, 2018 Cellectar’s CLR 131 Receives FDA Rare Pediatric Disease Designation for the Treatment of Ewing’s Sarcoma Learn More
Aug 10, 2018 Cellectar Reports 2018 Second Quarter Financial Results and Provides Business Update Learn More